India to Guatemala: Linagliptin Export Trade Route

The India to Guatemala Linagliptin corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $53.4K USD. The route is dominated by VEE EXCEL DRUGS AND PHARMACEUTICALS PRIVATE LIMITE, which alone accounts for roughly 72% of all export value, reflecting the consolidated nature of India's linagliptin manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $13.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with linagliptin's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 11.3%, placing it at rank #13 among India's top linagliptin export destinations globally.

On the import side, key buyers of Indian linagliptin in Guatemala include AVIV FARMACEUTICA S.A, PRUDENTIAL PHARMACEUTICALS SA, PRUDENTIAL PHARMACEUTICALS S.A. AVIV FARMACEUTICA S.A is the single largest importer with 1 shipments valued at $38.3K USD.

India's linagliptin exports to Guatemala are driven primarily by a handful of large-scale manufacturers. VEE EXCEL DRUGS AND PHARMACEUTICALS PRIVATE LIMITE with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Guatemala benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VEE EXCEL DRUGS AND PHARMACEUTICALS PRIVATE LIMITE, PHOENIX BIOLOGICALS PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $13.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as western drugs and harmless medicines linagliptina 5mg tabletas recubiertas and western drugs and harmless medicines: linagliptina 5mg tabletas recubiertas (batch no:pbi05 mfg: 02/2025 exp:01/2028), suggesting that buyers in Guatemala tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AVIV FARMACEUTICA S.A is the largest importer with 1 shipments worth $38.3K USD — representing 72% of all linagliptin imports from India on this route.